Latest News

Clinical trial: Oral drug improves exercise capacity in teens with congenital heart defects

The largest-ever clinical trial of a medication for pediatric cardiology patients found that an oral drug significantly improved exercise capacity in adolescent patients with severe, congenital single-ventricle heart defects.

Source link

Related posts

HSE Opportunity for General Practitioner in the GMS Scheme


Roche scores first U.S. approval of immunotherapy for breast cancer


Newly developed algorithms can predict and correct errors in single cell analyses


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy